• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Ocera Therapeutics Inc

+ Add to Watchlist

6TY1:GR

4.737 EUR 0.101 2.18%

As of 06:58:57 ET on 12/29/2014.

Snapshot for Ocera Therapeutics Inc (6TY1)

Open: 4.758 Day's Range: 4.729 - 4.759 Volume: 0
Previous Close: 4.636 52wk Range: 3.636 - 14.161 1-Yr Rtn: -44.65%

Stock Chart for 6TY1

No chart data available.
  • 6TY1:GR 4.758
  • 1D
  • 1M
  • 1Y
4.636
Interactive 6TY1 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 6TY1

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -1.5070
Est. PEG Ratio -
Market Cap (M EUR) 93.36
Shares Outstanding (M) 19.74
30 Day Average Volume 295
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/13/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 6TY1

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for 6TY1

Ocera Therapeutics, Inc. develops novel therapeutics products. The Company's products are designed to treat liver and gastrointestinal diseases.

Linda S GraisPresident/CEOMichael ByrnesChief Financial Officer
Rajiv PatniChief Development Officer
More Company Profile & Key Executives for 6TY1

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil